useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established
Profusions does not prescribe peptides for bodybuilding, athletic performance, or cosmetic enhancement
People under higher oxidative stress or seeking specific benefits like skin health, immune support, or detoxification may require different amounts than those using glutathione for general wellness
It plays a significant role in tissue repair, regeneration, and inflammation reduction
AGS cells were also incubated with BME or medium alone for the duration of infection
